| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.74B | -7.4% |
| Cost of Revenue | $2.20B | -5.4% |
| Gross Profit | $533.4M | -15.2% |
| R&D Expense | $45.4M | +3.9% |
| SG&A Expense | $707.6M | -7.8% |
| Operating Income | -$909.1M | -1.1% |
| Pre-tax Income | -$881.5M | -3.2% |
| Income Tax | -$23.3M | -40.4% |
| Net Income | -$858.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.0M | -26.8% |
| Accounts Receivable | $298.8M | -12.0% |
| Current Assets | $618.8M | -16.2% |
| Total Assets | $3.05B | -25.4% |
| Current Liabilities | $766.6M | -4.1% |
| Long-term Debt | $2.79B | -2.7% |
| Total Liabilities | $4.06B | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39.9M | -89.4% |
| Capital Expenditures | $111.1M | +14.7% |
| Investing Cash Flow | -$86.6M | +9.8% |
| Financing Cash Flow | -$3.0M | +99.0% |
| Free Cash Flow | -$71.2M | -125.6% |
| -2.4% |
| EPS (Basic) | -$3.82 | +1.8% |
| EPS (Diluted) | -$3.82 | +1.8% |
| Stockholders' Equity |
| -$1.00B |
| -550.0% |